Research suggests estrogen may support GLP-1s ability to regulate cravings and metabolism
Retatrutide Dosing Explained Understanding the dosing schedule is a key part of switching from Tirzepatide to Retatrutide
Tirzepatide shows the lowest discontinuation rates due to adverse events in clinical trials (4-7%), followed closely by semaglutide (approximately 7%)
Tirzepatide Tirzepatide is currently the only long-acting glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 dual receptor agonist
Stay tuned , Blog #2 is coming soon
11 Consuming fewer calories is the goal for weight loss, but if those limited calories come from nutrient-poor foods, individuals risk malnutrition, fatigue, and excessive loss of muscle mass, which can negatively impact metabolism and long-term health